Anti-CEACAM6 Antibody

Expressed in neutrophils (PubMed:1378450) . Expressed in columnar epithelial and goblet cells of the colon (PubMed:10436421) . Expressed in numerous tumor cell lines (at protein level) (PubMed:16204051) .

Cell surface glycoprotein that plays a role in cell adhesion and tumor progression (PubMed:2803308, PubMed:2022629, PubMed:1378450, PubMed:8776764, PubMed:11590190, PubMed:10910050, PubMed:14724575, PubMed:16204051) . Intercellular adhesion occurs in a calcium- and fibronectin-independent manner (PubMed:2022629, PubMed:16204051) . Mediates homophilic and heterophilic cell adhesion with other carcinoembryonic antigen-related cell adhesion molecules, such as CEACAM5 and CEACAM8 (PubMed:2803308, PubMed:2022629, PubMed:8776764, PubMed:11590190, PubMed:16204051) . Heterophilic interaction with CEACAM8 occurs in activated neutrophils (PubMed:8776764) . Plays a role in neutrophil adhesion to cytokine-activated endothelial cells (PubMed:1378450) . Plays a role as an oncogene by promoting tumor progression; positively regulates cell migration, cell adhesion to endothelial cells and cell invasion (PubMed:16204051) . Also involved in the metastatic cascade process by inducing gain resistance to anoikis of pancreatic adenocarcinoma and colorectal carcinoma cells (PubMed:10910050, PubMed:14724575) .